Get access

Temozolomide for children and adolescents with diffuse intrinsic pontine glioma

  • Protocol
  • Intervention

Authors

  • Marc HA Jansen,

    Corresponding author
    1. VU University Medical Center, Department of Paediatrics, Division of Paediatric Oncology/Haematology, Amsterdam, Netherlands
    • Marc HA Jansen, Department of Paediatrics, Division of Paediatric Oncology/Haematology, VU University Medical Center, PO Box 7057, Amsterdam, 1007 MB, Netherlands. mh.jansen@vumc.nl.

    Search for more papers by this author
  • Susanna JE Veringa,

    1. VU University Medical Center, Department of Paediatrics, Division of Paediatric Oncology/Haematology, Amsterdam, Netherlands
    Search for more papers by this author
  • Dannis G van Vuurden,

    1. VU University Medical Center, Department of Paediatrics, Division of Paediatric Oncology/Haematology, Amsterdam, Netherlands
    Search for more papers by this author
  • Elvira C van Dalen,

    1. Emma Children's Hospital / Academic Medical Center, Department of Paediatric Oncology, Amsterdam, Netherlands
    Search for more papers by this author
  • Gertjan JL Kaspers

    1. VU University Medical Center, Department of Paediatrics, Division of Paediatric Oncology/Haematology, Amsterdam, Netherlands
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy of temozolomide in children and adolescents with newly diagnosed and progressive DIPG.

Get access to the full text of this article